Release Date: 20/02/18 10:50 Summary: Half Yearly Report and Accounts Price Sensitive: Yes Download Document 1.55MB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%